condition	mean	min	max
0.1 mm CuSO4,WT	0.0	0.0	0.0
1-napp-1,WT	11.16535	0.0	22.3307
1n,MATa,NaCl,WT	0.0	0.0	0.0
1n,MATa,WT	0.0	0.0	0.0
1n,MATa,unstressed,WT	0.0	0.0	0.0
1n,MATalpha,WT	0.0	0.0	0.0
1n,WT	0.0	0.0	0.0
1n,addition of 1nm-pp1,WT	0.0	0.0	0.0
200 mm hu,WT	0.0	0.0	0.0
39C,YPD,WT	0.0	0.0	0.0
SC-URA + 20g/l glucose,WT	0.0	0.0	0.0
SDC,WT	0.0	0.0	0.0
WT	1.2082609803921567	0.0	587.685
YEP + lactic acid + 2% gal,WT	0.0	0.0	0.0
YEP + lactic acid,WT	0.0	0.0	0.0
YP + 3% glycerol,WT	0.0	0.0	0.0
YPD,WT	0.0	0.0	0.0
YPDA,WT	0.0	0.0	0.0
YPEG,WT	0.0	0.0	0.0
azetidine,YPD,WT	0.0	0.0	0.0
cmk treatment,WT	7.881275	0.0	31.5251
dmso,WT	27.79595	0.0	55.5919
elutriation + 1nm-pp1,WT	0.0	0.0	0.0
fluco,YPD,WT	0.0	0.0	0.0
gal, 2h + hu 200 mm,WT	0.0	0.0	0.0
gal, 4h + hu 200 mm,WT	0.0	0.0	0.0
gal,WT	0.0	0.0	0.0
glucose,WT	0.0	0.0	0.0
heatshock,WT	1.7198883333333332	0.0	5.26946
hu, 1h,WT	0.0	0.0	0.0
hu, 2h,WT	0.0	0.0	0.0
hu, 4h,WT	0.0	0.0	0.0
log,WT	0.0	0.0	0.0
med 35 6aa,WT	0.0	0.0	0.0
med 35 ammonium,WT	0.0	0.0	0.0
med 35 complete,WT	0.0	0.0	0.0
menadione,YPD,WT	0.0	0.0	0.0
mid-log,WT	0.0	0.0	0.0
mid-log,untreated,WT	0.0	0.0	0.0
mid-log,vts1 OE,WT	0.0	0.0	0.0
min med, chemostat,WT	0.0	0.0	0.0
rap,YPD,WT	0.0	0.0	0.0
ribo depletion,WT	0.0	0.0	0.0
salt,YPD,WT	0.0	0.0	0.0
stat,WT	0.0	0.0	0.0
syn dext,WT	0.0	0.0	0.0
synthetic complete med,20C,WT	0.0	0.0	0.0
synthetic defined med,WT	0.0	0.0	0.0
treated,WT	0.0	0.0	0.0
tunicamycin,YPD,WT	0.0	0.0	0.0
untreated,WT	0.35960214285714287	0.0	5.03443
ypsorbitol (2.02%),YPD,WT	0.0	0.0	0.0